Oncology Institute of Vojvodina
In research, Oncology Institute of Vojvodina stands highest in Medicine (#7,511 of 10,443 worldwide) and Health Sciences (#9,260 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 11.0× its share of world research.
- World rank, 2022–2025
- #12,224 of 28,054 · #15,581 all time
- Rank in Serbia
- #17 of 71
- Research works
- 1.7k ▼ 10% vs 2013–17
- Citations
- 19k 10.8 per fractional work
- Top-10% rate
- 10.3% record average 16.5%
- Open access
- 50% world 28%
What is Oncology Institute of Vojvodina known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,511 of 10,443 | 8.8% | 141 | #7555 | |
| Health SciencesDomain | #9,260 of 11,982 | 8.8% | 145 | #9734 |
Each strip is that field’s whole ranked pool, with the notch where Oncology Institute of Vojvodina sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Oncology Institute of Vojvodina specialise in?
Where its research is concentrated relative to its size: Oncology takes 11.0× the share of its output that it takes of world research.
- OncologySubfield · 27.9 works11×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.2×. Every wedge is a field page.
- Medicine 3.2×
- Immunology and Microbiology 2.9×
- Pharmacology, Toxicology and Pharmaceutics 2.9×
- Chemistry 2.9×
- Biochemistry, Genetics and Molecular Biology 2.3×
- Nursing 1.4×
- Agricultural and Biological Sciences 0.7×
- Neuroscience 0.6×
- Economics, Econometrics and Finance 0.5×
- Decision Sciences 0.5×
- Health Professions 0.4×
- Chemical Engineering 0.4×
- Veterinary 0.4×
- Dentistry 0.3×
- Materials Science 0.3×
- Physics and Astronomy 0.2×
- Computer Science 0.2×
- Psychology 0.2×
- Earth and Planetary Sciences 0.2×
- Environmental Science 0.2×
- Energy 0.1×
- Engineering 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.1×
- Mathematics 0.1×
- Arts and Humanities 0.1×
Who are the top researchers at Oncology Institute of Vojvodina?
Ranked on the composite score, Zorica D. Juranić, Ivana Z. Matić and Jasna Mihailović lead among researchers whose main affiliation is Oncology Institute of Vojvodina.
- 1 Zorica D. Juranić Serbia · #400,554 worldwide 98 citations · 29 works
- 2 Ivana Z. Matić Serbia · #590,213 worldwide 75 citations · 22 works
- 3 Jasna Mihailović Serbia · #617,386 worldwide 28 citations · 21 works
- 4 Sneẑana Šušnjar Serbia · #674,596 worldwide 47 citations · 25 works
- 5 Aljoša Mandić Serbia · #706,000 worldwide 26 citations · 21 works
- 6 Radan Džodić Serbia · #794,267 worldwide 15 citations · 25 works
- 7 Tatjana Stanojković Serbia · #854,673 worldwide 55 citations · 28 works
- 8 Igor Djurisic Serbia · #914,334 worldwide 11 citations · 19 works
- 9 S Jelić Serbia · #923,920 worldwide 9 citations · 18 works
- 10 Ivan Marković Serbia · #985,598 worldwide 14 citations · 31 works
Which keywords describe research at Oncology Institute of Vojvodina?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Clinical Practice Guidelines, Tumor Microenvironment, Cancer, Survival Analysis, Immunotherapy and Metastasis.
- PD-1 and PD-L1
- Adjuvant Therapy
- Genomic Instability
- Ultrasound
- Radiation Therapy
- Cancer Incidence
- Apoptosis
- Anti-inflammatory
- Cancer Therapy
- Medicinal Chemistry
- Prognostic Factors
- Cervical Cancer
- Targeted Therapy
- Breast Cancer
- Metastasis
- Oxidative Stress
- Tumor Microenvironment
- Inflammation
- Cancer
- Epidemiology
- Chemotherapy
- Radiotherapy
- Clinical Practice Guidelines
- Immunotherapy
- Survival Analysis
- Clinical Trials
- Neoadjuvant Therapy
- Biomarkers
- Antioxidant
- Molecular Classification
- Anticancer Agents
- Precision Medicine
- Pharmacology
- Sentinel Lymph Node Biopsy
- Chemoradiotherapy
- BRAF Mutation
- Drug Discovery
- Robotic Surgery
- Human Papillomavirus
- Immune Checkpoint Blockade
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy19▲ 12×20 topics
- Epidemiology14▲ 1.54×49 topics
- Radiotherapy13▲ 15×10 topics
- Cancer12▲ 4.1×37 topics
- Clinical Practice Guidelines11▲ 9.1×10 topics
- Inflammation11▲ 2.3×39 topics
- Immunotherapy10▲ 6.0×15 topics
- Tumor Microenvironment10▲ 9.6×7 topics
- Survival Analysis9▲ 15×6 topics
- Oxidative Stress9▲ 2.4×29 topics
- Clinical Trials9▲ 5.8×12 topics
- Metastasis8▲ 11×10 topics
- Neoadjuvant Therapy7▲ 14×5 topics
- Breast Cancer7▲ 13×9 topics
- Biomarkers7▲ 4.3×13 topics
- Targeted Therapy7▲ 13×5 topics
- Antioxidant6▲ 4.2×23 topics
- Cervical Cancer6▲ 27×2 topics
- Molecular Classification6▲ 19×4 topics
- Prognostic Factors6▲ 6.4×13 topics
- Anticancer Agents6▲ 18×7 topics
- Medicinal Chemistry6▲ 8.9×7 topics
- Precision Medicine6▲ 5.3×5 topics
- Cancer Therapy5▲ 4.2×13 topics
- Pharmacology5▲ 9.5×13 topics
- Anti-inflammatory5▲ 7.8×16 topics
- Sentinel Lymph Node Biopsy5▲ 26×2 topics
- Apoptosis5▲ 6.8×11 topics
- Chemoradiotherapy5▲ 40×2 topics
- Cancer Incidence5▲ 15×4 topics
- BRAF Mutation4▲ 28×2 topics
- Radiation Therapy4▲ 15×5 topics
- Drug Discovery4▲ 8.6×7 topics
- Ultrasound4▲ 19×3 topics
- Robotic Surgery4▲ 13×3 topics
- Genomic Instability4▲ 16×3 topics
- Human Papillomavirus4▲ 15×3 topics
- Adjuvant Therapy4▲ 14×2 topics
- Immune Checkpoint Blockade4▲ 16×1 topic
- PD-1 and PD-L14▲ 16×1 topic
Which research topics does Oncology Institute of Vojvodina publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Endometrial and Cervical Cancer Treatments, Thyroid Cancer Diagnosis and Treatment and Pancreatic and Hepatic Oncology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 2 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 4 works
- 3 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 3 works
- 4 Pancreatic and Hepatic Oncology Research Oncology 3 works
- 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
- 6 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 8 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 9 Cervical Cancer and HPV Research Epidemiology 3 works
- 10 Cancer Genomics and Diagnostics Cancer Research 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Oncology Institute of Vojvodina's research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Novi Sad
- University of Novi Sad
- Klinički centar Vojvodine
- Institute of Field and Vegetable Crops
- Pokrajinski Sekretarijat za Nauku i Tehnološki Razvoj
- Scientific Veterinary Institute "Novi Sad"
- Institute of Public Health of Vojvodina
- RT-RK Institute for Computer Based Systems (Serbia)
- Institut za zdravstvenu zaštitu dece i omladine Vojvodine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.